Π”ΠΈΠΏΠ»ΠΎΠΌ, курсовая, ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½Π°Ρ Ρ€Π°Π±ΠΎΡ‚Π°
ΠŸΠΎΠΌΠΎΡ‰ΡŒ Π² написании студСнчСских Ρ€Π°Π±ΠΎΡ‚

Бписок Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹. 
ΠœΠ΅Π΄ΠΈΠ°Ρ‚ΠΎΡ€Ρ‹ Π½Π΅Ρ€Π²Π½ΠΎΠΉ систСмы

Π Π΅Ρ„Π΅Ρ€Π°Ρ‚ΠŸΠΎΠΌΠΎΡ‰ΡŒ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈΠ£Π·Π½Π°Ρ‚ΡŒ ΡΡ‚ΠΎΠΈΠΌΠΎΡΡ‚ΡŒΠΌΠΎΠ΅ΠΉ Ρ€Π°Π±ΠΎΡ‚Ρ‹

Lange, K.W. L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction / K.W. Lange // Psycho-pharmacology. — 1992. — Vol. 107. — P. 394βˆ’404. Aradi, I. Postsynaptic effects of GABAergic synaptic diversity: regulation of neuronal excitability by changes in IPSC variance / I. Aradi // Neuropharmacology. — 2002. — Vol. 43. — P… Π§ΠΈΡ‚Π°Ρ‚ΡŒ Π΅Ρ‰Ρ‘ >

Бписок Π»ΠΈΡ‚Π΅Ρ€Π°Ρ‚ΡƒΡ€Ρ‹. ΠœΠ΅Π΄ΠΈΠ°Ρ‚ΠΎΡ€Ρ‹ Π½Π΅Ρ€Π²Π½ΠΎΠΉ систСмы (Ρ€Π΅Ρ„Π΅Ρ€Π°Ρ‚, курсовая, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒΠ½Π°Ρ)

НСйрохимия / ΠΏΠΎΠ΄ Ρ€Π΅Π΄. И. П. ΠΡˆΠΌΠ°Ρ€ΠΈΠ½Π°, П. Π’. Π‘Ρ‚ΡƒΠΊΠ°Π»ΠΎΠ²Π°. — Πœ.: Изд. Π˜Π½ΡΡ‚ΠΈΡ‚ΡƒΡ‚Π° биомСдицинской Ρ…ΠΈΠΌΠΈΠΈ РАМН, 1996.

НСйроэндокринология / ΠΏΠΎΠ΄ Ρ€Π΅Π΄. А. Π›. ПолСнова. — Π‘Пб.: Наука, 1993.

РаСвский, К. Π‘. ΠœΠ΅Π΄ΠΈΠ°Ρ‚ΠΎΡ€Π½Ρ‹Π΅ аминокислоты / К. Π‘. РаСвский, Π’. П. Π“Π΅ΠΎΡ€Π³ΠΈΠ΅Π².

— Πœ., 1986. — 240 с.

Π₯ΡƒΡ…ΠΎ, Π€. НСйрохимия. ΠžΡΠ½ΠΎΠ²Ρ‹ ΠΈ ΠΏΡ€ΠΈΠ½Ρ†ΠΈΠΏΡ‹ / Π€. Π₯ΡƒΡ…ΠΎ. — Πœ.: ΠœΠΈΡ€, 1990.

Aradi, I. Postsynaptic effects of GABAergic synaptic diversity: regulation of neuronal excitability by changes in IPSC variance / I. Aradi [et al.] // Neuropharmacology. — 2002. — Vol. 43. — P. 511−522.

Bush, P. GABAergic inhibitory control of the transient and sustained components of orientation selectivity in a model microcolumn in layer 4 of cat visual cortex / P. Bush, N. Priebe // Neural Computation. — 1998. — Vol. 10. — P. 855- 867.

Davis, K.L. Neuropsychopharmacology: The 5th Generation of Progress. American College of Neuropsychopharmacology / K.L. Davis [et al.]. — 2003.

Drevets, W.C. Subgenual prefrontal cortex abnormalities in mood disorders / W.C. Drevets [et al.] // Nature. — 1997. — Vol. 386. — P. 824−827.

Fibiger, H.C. Neurobiology of depression: focus on dopamine / H.C. Fibiger // Advances in Biochemical Psychopharmacology. — 1995. — Vol. 49. — P. 1−17.

Glickstein, S.B. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention / S.B. Glickstein [et al.] // Cerebral Cortex. — 2005. — Vol. 15(7). — P. 1016−1024.

Glickstein, S.B. Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits / S.B. Glickstein [et al.] // The Journal of Neuroscience. — 2002. — Vol. 22(13). — P. 5619−5629.

Lange, K.W. L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction / K.W. Lange [et al.] // Psycho-pharmacology. — 1992. — Vol. 107. — P. 394−404.

Olsen, R.W. Comparative Invertebrate Neurochemistry / R.W. Olsen, George G. Lunt. — Cornell Univ. Press, 1988.

Siegel, George J. Basic Neurochemistry. Molecular, Cellular, and Medical Aspects / George J. Siegel [et al.]. — Williams & Wilkins, 1999.

Tanda, G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential / G. Tanda [et al.] // Psychopharmacology. — 1994. — Vol. 115.P. 285−288.

ΠŸΠΎΠΊΠ°Π·Π°Ρ‚ΡŒ вСсь тСкст
Π—Π°ΠΏΠΎΠ»Π½ΠΈΡ‚ΡŒ Ρ„ΠΎΡ€ΠΌΡƒ Ρ‚Π΅ΠΊΡƒΡ‰Π΅ΠΉ Ρ€Π°Π±ΠΎΡ‚ΠΎΠΉ